Berger M, Wood H G
J Biol Chem. 1976 Nov 25;251(22):7021-34.
Antisera reactive with the subunits of transcarboxylase were produced by injecting rabbits with the 12 SH and 5 SE subunits prepared from trypsin-treated enzyme and with the 12 SH subunit prepared from native transcarboxylase by avidin-Sepharose chromatography. Biotinyl peptides (46 and 65 amino acid residues), released from the enzyme by brief trypsin treatment, formed complexes with avidin and this noncovalent conjugate was used as an antigen to prepare antibodies reactive with the 1.3 SE biotin carboxyl carrier protein. All of these antisera were capable of inhibiting and precipitating intact transcarboxylase. In competitive binding experiments utilizing enzyme inhibition to detect antibody binding, it was found that only the 5 SE subunit was capable of preventing the anti-5 SE sera from inhibiting the enzyme. This technique is useful as a rapid, specific assay for the 5 SE subunit. Both the 5 SE and 12 SH subunits were capable of preventing the anti-12 SH sera from inhibiting the enzyme. To further study this apparent cross-reactivity, the antisera were tested for their capacity to inhibit the partial reactions of transcarboxylase as catalyzed by the isolated subunits. These studies revealed that the anit-12 SH serum inhibits the partial reaction catalyzed by the 12 SH subunit, but preincubation with the 5 SE subunit does not relieve this inhibition, confirming that specific antibody against the 12 SH subunit was formed. These studies also showed that the anti-12 SH serum could inhibit the 5 SE partial reaction, apparently demonstrating cross-reactivity with the 5 SE subunits of the intact enzyme. A panel of immunologic methods was used to characterize the cross-reactivity and quantitate any cross-contamination of the subunit preparations. Passive hemagglutination-hemagglutination inhibition, double immunodiffusion in gels, and competitive precipitation of radioactive antigen all demonstrated cross-reactivity between the isolated subunits and the antisera. Although the subunit preparations apparently are cross-contaminated to a minor extent, this seems insufficient to account for the quantitative aspects of the immunologic cross-reactivity of the subunits with the antisera. Structural homology between the subunits of transcarboxylase is considered to be responsible for the observed cross-reactivity.
通过向兔子注射用胰蛋白酶处理的酶制备的12个SH亚基和5个SE亚基,以及通过抗生物素蛋白-琼脂糖层析从天然转羧酶制备的12个SH亚基,产生了与转羧酶亚基反应的抗血清。通过短暂的胰蛋白酶处理从酶中释放出的生物素化肽(46和65个氨基酸残基)与抗生物素蛋白形成复合物,这种非共价缀合物被用作抗原,以制备与1.3 SE生物素羧基载体蛋白反应的抗体。所有这些抗血清都能够抑制和沉淀完整的转羧酶。在利用酶抑制来检测抗体结合的竞争性结合实验中,发现只有5 SE亚基能够阻止抗5 SE血清抑制该酶。该技术作为一种快速、特异性的5 SE亚基检测方法很有用。5 SE和12 SH亚基都能够阻止抗12 SH血清抑制该酶。为了进一步研究这种明显的交叉反应性,测试了抗血清抑制由分离的亚基催化的转羧酶部分反应的能力。这些研究表明,抗12 SH血清抑制由12 SH亚基催化的部分反应,但与5 SE亚基预孵育并不能减轻这种抑制,证实形成了针对12 SH亚基的特异性抗体。这些研究还表明,抗12 SH血清可以抑制5 SE部分反应,显然表明与完整酶的5 SE亚基有交叉反应性。使用一组免疫方法来表征交叉反应性并定量亚基制剂的任何交叉污染。被动血凝-血凝抑制、凝胶中的双向免疫扩散以及放射性抗原的竞争性沉淀都证明了分离的亚基与抗血清之间的交叉反应性。尽管亚基制剂显然有轻微的交叉污染,但这似乎不足以解释亚基与抗血清免疫交叉反应性的定量方面。转羧酶亚基之间的结构同源性被认为是观察到的交叉反应性的原因。